USDCHF is trading extremely weak after a minor recovery till 0.89082 on broad-based US dollar selling. US FDA has cleared Pfizer - BioNtech COVID-19 vaccine on Friday. The demand for Safe-haven assets like the dollar has decreased on COVID-19 vaccine optimism. It was one of the worst performers in the past 7 months and lost more than 1350 pips from a high of 1.02369. The slight delay in Coronavirus stimulus is supporting the US dollar at lower levels.
The pair is facing strong intraday resistance at 0.8920 and any break above will take to the next level till 0.8945/0.8988. Minor bullishness only above 0.9000.
On the lower side, the near term support is around 0.8850, and a dip till 0.8800 is possible.
It is good to sell on rallies around 0.8900 with SL around 0.8920 for TP of 0.8800.


JPY Pairs Action Bias: EURJPY Leads as Bullish Standout Amid Mixed Momentum
FxWirePro: USD/JPY eases ahead of Fed decision , Intervention risks linger
FxWirePro : GBP/NZD strongly bearish despite upside attempts
FxWirePro: USD/JPY edges higher as focus shifts to BOJ decision
FxWirePro:EUR/NZD gains some upside momentum but still bearish
FxWirePro: GBP/AUD gains some upside momentum but still bearish
FxWirePro: USD/CAD slips after Fed holds rates steady
FxWirePro: GBP/AUD gains above 1.9200 level , upside pressure builds
FxWirePro- Major Pair levels and bias summary
FxWirePro: USD/CAD runs out of steam but maintains bullish outlook
FxWirePro: AUD/USD falls after softer-than-expected Australian Q2 CPI
FxWirePro: USD/ CNY remains soft ahead of Fed decision
Buy the Dips on EUR/JPY: Bullish Structure Points to 188 Target Ahead of Fed
FxWirePro: USD/ZAR firms ahead of Fed interest rate decision
FxWirePro: NZD/USD neutral in the near-term, scope for downward resumption 



